ArticleFrontiers in immunology2022

Virotherapy combined with anti-PD-1 transiently reshapes the tumor immune environment and induces anti-tumor immunity in a preclinical PDAC model.

Rūta Veinalde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.